chr1_+_32992131
|
8.076
|
|
|
|
chr19_-_6718417
|
7.906
|
NM_005490
|
SH2D3A
|
SH2 domain containing 3A
|
chr19_-_45888259
|
5.194
|
NM_004756
|
NUMBL
|
numb homolog (Drosophila)-like
|
chr5_-_16989371
|
5.008
|
NM_012334
|
MYO10
|
myosin X
|
chr8_-_99906944
|
4.516
|
NM_006281
|
STK3
|
serine/threonine kinase 3
|
chr8_+_1699276
|
4.421
|
NM_018941
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
|
chr17_-_37196463
|
4.413
|
NM_002230
NM_021991
|
JUP
|
junction plakoglobin
|
chr11_-_94603857
|
3.618
|
NM_144665
|
SESN3
|
sestrin 3
|
chr1_-_208046011
|
3.500
|
NM_006147
|
IRF6
|
interferon regulatory factor 6
|
chr8_-_127639647
|
3.433
|
|
FAM84B
|
family with sequence similarity 84, member B
|
chr5_-_9599157
|
3.430
|
NM_003966
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
chr9_-_129371171
|
3.409
|
NM_022833
|
FAM129B
|
family with sequence similarity 129, member B
|
chr2_+_24153255
|
3.371
|
|
LOC375190
|
hypothetical protein LOC375190
|
chr9_-_129370954
|
3.314
|
|
FAM129B
|
family with sequence similarity 129, member B
|
chr18_-_50004458
|
3.230
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
chr3_-_46710137
|
3.162
|
NM_001190707
NM_147129
|
ALS2CL
|
ALS2 C-terminal like
|
chr8_-_144887876
|
3.144
|
NM_198488
|
FAM83H
|
family with sequence similarity 83, member H
|
chr22_-_37062114
|
3.117
|
|
CSNK1E
|
casein kinase 1, epsilon
|
chr10_-_80875097
|
3.110
|
NM_153367
|
ZCCHC24
|
zinc finger, CCHC domain containing 24
|
chr19_+_54558798
|
3.054
|
NM_001197302
NM_001197301
NM_014419
|
DKKL1
|
dickkopf-like 1
|
chr20_-_56317894
|
2.969
|
|
PPP4R1L
|
protein phosphatase 4, regulatory subunit 1-like
|
chr3_-_52065130
|
2.961
|
NM_001947
|
DUSP7
|
dual specificity phosphatase 7
|
chrX_+_15666312
|
2.960
|
NM_007220
|
CA5B
|
carbonic anhydrase VB, mitochondrial
|
chr2_-_235070431
|
2.938
|
NM_005737
|
ARL4C
|
ADP-ribosylation factor-like 4C
|
chr7_-_27120015
|
2.918
|
|
HOXA3
|
homeobox A3
|
chr9_+_90193058
|
2.914
|
NM_006717
|
SPIN1
|
spindlin 1
|
chr17_+_9489578
|
2.773
|
NM_153210
|
USP43
|
ubiquitin specific peptidase 43
|
chr18_-_50004770
|
2.758
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
chr16_-_65287967
|
2.727
|
NM_178818
NM_181521
|
CMTM4
|
CKLF-like MARVEL transmembrane domain containing 4
|
chr10_-_126839546
|
2.660
|
NM_001083914
|
CTBP2
|
C-terminal binding protein 2
|
chr18_+_19706979
|
2.648
|
NM_000227
NM_001127718
|
LAMA3
|
laminin, alpha 3
|
chr19_-_45663463
|
2.643
|
NM_000713
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH))
|
chr4_+_85723080
|
2.641
|
NM_001263
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1
|
chr5_-_16989290
|
2.631
|
|
MYO10
|
myosin X
|
chr8_-_127639892
|
2.606
|
NM_174911
|
FAM84B
|
family with sequence similarity 84, member B
|
chr17_-_46553083
|
2.604
|
NM_001130528
NM_003971
|
SPAG9
|
sperm associated antigen 9
|
chr19_+_43447262
|
2.604
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
chr1_+_26728846
|
2.598
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
chr1_+_28458546
|
2.590
|
NM_031459
|
SESN2
|
sestrin 2
|
chr20_+_56318245
|
2.550
|
|
RAB22A
|
RAB22A, member RAS oncogene family
|
chr18_-_26935883
|
2.528
|
NM_004949
NM_024422
|
DSC2
|
desmocollin 2
|
chr11_+_384238
|
2.504
|
|
PKP3
|
plakophilin 3
|
chr19_+_61742111
|
2.486
|
NM_020828
|
ZFP28
|
zinc finger protein 28 homolog (mouse)
|
chr17_+_72789086
|
2.478
|
NM_001113491
|
SEPT9
|
septin 9
|
chr8_-_102031943
|
2.471
|
NM_001135702
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
|
chr17_+_19081267
|
2.453
|
NM_001102664
NM_014964
NM_148921
|
EPN2
|
epsin 2
|
chr22_+_36632242
|
2.451
|
NM_033386
|
MICALL1
|
MICAL-like 1
|
chr7_+_115926855
|
2.440
|
|
CAV2
|
caveolin 2
|
chr13_+_72531098
|
2.402
|
NM_001730
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
chr1_-_113059396
|
2.389
|
NM_005167
|
PPM1J
|
protein phosphatase, Mg2+/Mn2+ dependent, 1J
|
chr11_-_6212421
|
2.379
|
|
FAM160A2
|
family with sequence similarity 160, member A2
|
chr4_+_154606900
|
2.374
|
NM_001131007
NM_015196
|
KIAA0922
|
KIAA0922
|
chr2_+_238265617
|
2.372
|
|
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1
|
chr8_+_144888275
|
2.355
|
|
LOC100128338
|
hypothetical LOC100128338
|
chr13_+_41520888
|
2.354
|
NM_152910
NM_178009
|
DGKH
|
diacylglycerol kinase, eta
|
chr11_-_6212449
|
2.343
|
|
FAM160A2
|
family with sequence similarity 160, member A2
|
chr2_+_178767317
|
2.334
|
NM_032523
|
OSBPL6
|
oxysterol binding protein-like 6
|
chr2_+_24153174
|
2.334
|
|
|
|
chr19_-_16868674
|
2.331
|
|
CPAMD8
|
C3 and PZP-like, alpha-2-macroglobulin domain containing 8
|
chr17_+_45488330
|
2.328
|
NM_002204
NM_005501
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
chr4_+_79691875
|
2.322
|
|
ANXA3
|
annexin A3
|
chr11_-_67329246
|
2.316
|
|
LOC645332
|
family with sequence similarity 86, member A pseudogene
|
chrX_-_134883798
|
2.312
|
NM_173470
|
MMGT1
|
membrane magnesium transporter 1
|
chr4_+_87734489
|
2.295
|
NM_006264
NM_080683
NM_080684
NM_080685
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
chr11_+_384199
|
2.291
|
NM_007183
|
PKP3
|
plakophilin 3
|
chr12_-_46585032
|
2.283
|
NM_000376
NM_001017535
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
chr11_-_6451561
|
2.267
|
NM_006458
NM_033278
|
TRIM3
|
tripartite motif containing 3
|
chr21_+_32706615
|
2.248
|
NM_058187
|
C21orf63
|
chromosome 21 open reading frame 63
|
chr6_-_35572694
|
2.233
|
NM_003214
|
TEAD3
|
TEA domain family member 3
|
chr1_+_26728827
|
2.229
|
NM_002953
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
chr20_+_56318415
|
2.227
|
|
RAB22A
|
RAB22A, member RAS oncogene family
|
chr3_+_137167296
|
2.225
|
|
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha
|
chr1_-_85514580
|
2.216
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
chr2_+_24152799
|
2.194
|
|
|
|
chr3_+_160964574
|
2.191
|
|
SCHIP1
|
schwannomin interacting protein 1
|
chr19_+_45807909
|
2.191
|
|
|
|
chr5_-_2804768
|
2.188
|
NM_001134222
NM_033267
|
IRX2
|
iroquois homeobox 2
|
chr18_+_59295123
|
2.186
|
NM_002639
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
chr1_-_117011824
|
2.168
|
NM_001007237
NM_001542
|
IGSF3
|
immunoglobulin superfamily, member 3
|
chr1_+_26728839
|
2.166
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
chr20_+_56318155
|
2.166
|
NM_020673
|
RAB22A
|
RAB22A, member RAS oncogene family
|
chrX_-_149817785
|
2.139
|
NM_001184808
NM_031462
NM_134445
NM_134446
|
CD99L2
|
CD99 molecule-like 2
|
chr17_+_24079924
|
2.137
|
NM_178170
|
NEK8
|
NIMA (never in mitosis gene a)- related kinase 8
|
chr17_-_17667580
|
2.135
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
chr8_+_1699418
|
2.132
|
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
|
chr1_+_182622987
|
2.130
|
|
C1orf21
|
chromosome 1 open reading frame 21
|
chr12_-_45759691
|
2.124
|
NM_001143668
NM_181847
|
AMIGO2
|
adhesion molecule with Ig-like domain 2
|
chr5_-_114660139
|
2.121
|
NM_001040440
|
CCDC112
|
coiled-coil domain containing 112
|
chr6_-_6632197
|
2.116
|
|
|
|
chr1_-_38243747
|
2.107
|
NM_004468
|
FHL3
|
four and a half LIM domains 3
|
chr13_-_109236897
|
2.097
|
NM_003749
|
IRS2
|
insulin receptor substrate 2
|
chr15_+_39907447
|
2.095
|
NM_001114632
NM_001198588
NM_005090
|
JMJD7
JMJD7-PLA2G4B
|
jumonji domain containing 7
JMJD7-PLA2G4B readthrough
|
chr11_-_6212467
|
2.089
|
NM_001098794
NM_032127
|
FAM160A2
|
family with sequence similarity 160, member A2
|
chr9_-_35101592
|
2.079
|
|
KIAA1539
|
KIAA1539
|
chr19_-_12747263
|
2.076
|
|
HOOK2
|
hook homolog 2 (Drosophila)
|
chr1_+_231530136
|
2.075
|
NM_032435
|
KIAA1804
|
mixed lineage kinase 4
|
chr19_-_6061491
|
2.066
|
|
RFX2
|
regulatory factor X, 2 (influences HLA class II expression)
|
chr9_-_109291575
|
2.064
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
chr22_-_17489718
|
2.061
|
|
DGCR2
|
DiGeorge syndrome critical region gene 2
|
chr19_+_60283571
|
2.055
|
NM_017729
|
EPS8L1
|
EPS8-like 1
|
chr8_-_145085616
|
2.053
|
NM_201384
|
PLEC
|
plectin
|
chr1_-_115060904
|
2.047
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
chr15_-_58477407
|
2.045
|
NM_001002857
NM_001002858
NM_001136015
NM_004039
|
ANXA2
|
annexin A2
|
chr20_-_33329319
|
2.039
|
|
EDEM2
|
ER degradation enhancer, mannosidase alpha-like 2
|
chr5_+_96024434
|
2.038
|
|
CAST
|
calpastatin
|
chr12_+_8958397
|
2.034
|
NM_004426
|
PHC1
|
polyhomeotic homolog 1 (Drosophila)
|
chr12_+_51777715
|
2.028
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
chr1_-_173428455
|
2.022
|
NM_001162895
NM_014656
NM_001162893
NM_001162894
|
KIAA0040
|
KIAA0040
|
chr2_-_9061193
|
2.018
|
NM_138799
|
MBOAT2
|
membrane bound O-acyltransferase domain containing 2
|
chr7_-_105712646
|
2.006
|
NM_005746
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
chr19_+_40298571
|
2.005
|
NM_001136007
NM_001136008
NM_001136009
NM_001136010
NM_001136011
NM_001136012
NM_005971
NM_021910
|
FXYD3
|
FXYD domain containing ion transport regulator 3
|
chr1_-_115060857
|
1.990
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
chr8_+_142207866
|
1.988
|
NM_014957
|
DENND3
|
DENN/MADD domain containing 3
|
chr11_-_33678861
|
1.969
|
NM_001166692
|
C11orf91
|
chromosome 11 open reading frame 91
|
chr19_+_53520632
|
1.961
|
|
EMP3
|
epithelial membrane protein 3
|
chr1_-_150232927
|
1.952
|
|
S100A10
|
S100 calcium binding protein A10
|
chr1_-_38243716
|
1.947
|
|
FHL3
|
four and a half LIM domains 3
|
chrX_-_135161185
|
1.945
|
NM_001173517
NM_024597
|
MAP7D3
|
MAP7 domain containing 3
|
chr8_-_22044463
|
1.942
|
NM_005144
NM_018411
|
HR
|
hairless homolog (mouse)
|
chr12_-_102759098
|
1.941
|
NM_001031701
|
NT5DC3
|
5'-nucleotidase domain containing 3
|
chr8_-_134378630
|
1.940
|
NM_001135242
NM_006096
|
NDRG1
|
N-myc downstream regulated 1
|
chr2_-_17563186
|
1.931
|
NM_001099218
|
RAD51AP2
|
RAD51 associated protein 2
|
chr7_-_72771853
|
1.929
|
NM_001165903
NM_004603
|
STX1A
|
syntaxin 1A (brain)
|
chr2_-_175060001
|
1.926
|
NM_001033045
NM_152529
|
GPR155
|
G protein-coupled receptor 155
|
chr8_+_94998258
|
1.924
|
NM_018444
NM_001161780
NM_001161779
NM_001161781
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1
|
chr2_+_10101081
|
1.906
|
NM_003597
NM_001177716
|
KLF11
|
Kruppel-like factor 11
|
chr19_-_6061561
|
1.898
|
NM_000635
NM_134433
|
RFX2
|
regulatory factor X, 2 (influences HLA class II expression)
|
chr21_-_36450448
|
1.893
|
|
LOC100506428
|
hypothetical LOC100506428
|
chr11_-_64368616
|
1.885
|
NM_017525
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like)
|
chr18_+_3439972
|
1.879
|
NM_173209
NM_173208
NM_003244
|
TGIF1
|
TGFB-induced factor homeobox 1
|
chr11_-_56848859
|
1.872
|
NM_033396
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa
|
chrX_-_149817720
|
1.865
|
|
CD99L2
|
CD99 molecule-like 2
|
chr2_+_241023703
|
1.857
|
NM_002081
|
GPC1
|
glypican 1
|
chr19_+_50535837
|
1.853
|
NM_177417
|
KLC3
|
kinesin light chain 3
|
chr17_+_30938391
|
1.844
|
NM_001030006
NM_001282
|
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit
|
chr17_+_45488356
|
1.836
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
chr19_-_51856129
|
1.833
|
NM_145056
|
DACT3
|
dapper, antagonist of beta-catenin, homolog 3 (Xenopus laevis)
|
chr3_+_137167153
|
1.833
|
NM_001190447
NM_002718
|
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha
|
chr22_+_27798887
|
1.819
|
NM_001039570
NM_032045
|
KREMEN1
|
kringle containing transmembrane protein 1
|
chr1_+_201862548
|
1.818
|
NM_001001396
NM_001684
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
chr17_+_77582774
|
1.815
|
NM_005052
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
chr22_-_37520092
|
1.800
|
NM_005740
|
DNAL4
|
dynein, axonemal, light chain 4
|
chr6_-_136913235
|
1.797
|
|
MAP7
|
microtubule-associated protein 7
|
chr14_-_104515738
|
1.794
|
NM_138420
|
AHNAK2
|
AHNAK nucleoprotein 2
|
chr12_-_32940931
|
1.785
|
NM_001005242
NM_004572
|
PKP2
|
plakophilin 2
|
chr4_-_125853166
|
1.782
|
NM_001167882
NM_020337
|
ANKRD50
|
ankyrin repeat domain 50
|
chr12_-_28014151
|
1.781
|
NM_198964
NM_198966
|
PTHLH
|
parathyroid hormone-like hormone
|
chr1_-_167603623
|
1.778
|
NM_013330
NM_197972
|
NME7
|
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase)
|
chr5_-_1935764
|
1.777
|
NM_016358
|
IRX4
|
iroquois homeobox 4
|
chr1_+_891739
|
1.770
|
NM_001160184
NM_032129
|
PLEKHN1
|
pleckstrin homology domain containing, family N member 1
|
chr1_+_24701886
|
1.768
|
NM_013441
|
RCAN3
|
RCAN family member 3
|
chr17_+_30938433
|
1.768
|
|
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit
|
chr7_+_16759845
|
1.766
|
NM_014399
|
TSPAN13
|
tetraspanin 13
|
chr17_-_24973940
|
1.751
|
|
CORO6
|
coronin 6
|
chr5_+_96023926
|
1.750
|
|
CAST
|
calpastatin
|
chr3_-_48607596
|
1.721
|
NM_000094
|
COL7A1
|
collagen, type VII, alpha 1
|
chr9_-_35101534
|
1.719
|
|
KIAA1539
|
KIAA1539
|
chr12_-_119187871
|
1.718
|
|
PXN
|
paxillin
|
chr8_+_32525269
|
1.711
|
NM_001160002
NM_001160004
NM_001160005
NM_001160007
NM_001160008
NM_004495
NM_013956
NM_013957
NM_013958
NM_013960
NM_013964
|
NRG1
|
neuregulin 1
|
chr5_+_2805261
|
1.708
|
NM_178569
|
C5orf38
|
chromosome 5 open reading frame 38
|
chr19_+_7891884
|
1.707
|
|
SNAPC2
|
small nuclear RNA activating complex, polypeptide 2, 45kDa
|
chr7_-_150305933
|
1.702
|
NM_000238
NM_172056
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2
|
chr2_-_158440587
|
1.698
|
NM_001111067
|
ACVR1
|
activin A receptor, type I
|
chr12_+_51777684
|
1.697
|
NM_002178
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
chr7_-_97868101
|
1.695
|
|
BAIAP2L1
|
BAI1-associated protein 2-like 1
|
chr16_+_65790514
|
1.695
|
NM_024712
|
ELMO3
|
engulfment and cell motility 3
|
chr2_+_235525355
|
1.695
|
NM_014521
|
SH3BP4
|
SH3-domain binding protein 4
|
chr1_-_150276091
|
1.679
|
|
S100A11
|
S100 calcium binding protein A11
|
chr17_-_78199384
|
1.666
|
NM_019613
|
WDR45L
|
WDR45-like
|
chr7_+_100302885
|
1.648
|
NM_003302
|
TRIP6
|
thyroid hormone receptor interactor 6
|
chr1_-_201043000
|
1.642
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
chr11_+_44543716
|
1.626
|
NM_001024844
NM_002231
|
CD82
|
CD82 molecule
|
chr1_+_44230011
|
1.624
|
|
CCDC24
|
coiled-coil domain containing 24
|
chr1_+_205561439
|
1.623
|
NM_000574
NM_001114752
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
chr9_+_129962292
|
1.612
|
NM_024112
|
C9orf16
|
chromosome 9 open reading frame 16
|
chr11_+_44543788
|
1.610
|
|
CD82
|
CD82 molecule
|
chrX_+_48915127
|
1.609
|
NM_002668
|
PLP2
|
proteolipid protein 2 (colonic epithelium-enriched)
|
chr7_-_127837242
|
1.606
|
NM_000883
NM_001102605
NM_001142576
NM_183243
|
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1
|
chr6_-_42527760
|
1.598
|
NM_033502
|
TRERF1
|
transcriptional regulating factor 1
|
chr12_-_53071285
|
1.597
|
NM_001130967
NM_001130968
|
ZNF385A
|
zinc finger protein 385A
|
chr19_-_48977247
|
1.593
|
NM_002250
|
KCNN4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
|
chr22_-_17489912
|
1.592
|
NM_001173533
NM_001173534
NM_001184781
NM_005137
|
DGCR2
|
DiGeorge syndrome critical region gene 2
|
chr1_-_115014151
|
1.590
|
NM_198459
|
DENND2C
|
DENN/MADD domain containing 2C
|
chr6_+_35528127
|
1.590
|
|
FANCE
|
Fanconi anemia, complementation group E
|
chr19_+_43447078
|
1.588
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
chr15_+_61356801
|
1.586
|
NM_001145646
NM_031301
|
APH1B
|
anterior pharynx defective 1 homolog B (C. elegans)
|
chr10_+_75427853
|
1.576
|
NM_003373
NM_014000
|
VCL
|
vinculin
|
chr10_+_112247614
|
1.575
|
NM_004419
|
DUSP5
|
dual specificity phosphatase 5
|
chrX_+_17303270
|
1.572
|
|
NHS
|
Nance-Horan syndrome (congenital cataracts and dental anomalies)
|
chr1_+_210672817
|
1.568
|
NM_013349
|
NENF
|
neuron derived neurotrophic factor
|
chr16_+_31036474
|
1.557
|
NM_032188
NM_182958
|
MYST1
|
MYST histone acetyltransferase 1
|
chr19_-_48976852
|
1.550
|
|
KCNN4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
|
chr3_-_125085834
|
1.548
|
NM_053025
NM_053026
NM_053027
NM_053028
|
MYLK
|
myosin light chain kinase
|
chr7_+_79602023
|
1.547
|
NM_002069
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
chr19_+_53520439
|
1.542
|
NM_001425
|
EMP3
|
epithelial membrane protein 3
|
chr12_-_53099203
|
1.538
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
chr18_+_55718171
|
1.535
|
NM_021127
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
chr1_+_30964199
|
1.531
|
|
LOC100129196
|
hypothetical LOC100129196
|
chr7_+_115953582
|
1.529
|
NM_001172896
NM_001172897
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
chr11_+_12088639
|
1.528
|
NM_014632
|
MICAL2
|
microtubule associated monoxygenase, calponin and LIM domain containing 2
|